Multicenter phase II study in advanced pancreatic adenocarcinoma patients treated with a combination of leucovorin, 5FU bolus and infusion, and emcitabine (FOLFUGEM regimen).

被引：0
|
作者：
Hammel, P [1 ]
Louvet, C [1 ]
Andre, T [1 ]
Vanica, R [1 ]
Landi, B [1 ]
Balosso, J [1 ]
Cattan, S [1 ]
Fonck, M [1 ]
Flesch, M [1 ]
Colin, P [1 ]
Gruson, T [1 ]
de Gramont, A [1 ]
机构：
[1] Hosp Beaujon, Clichy, France
来源：
GASTROENTEROLOGY | 1999年 / 116卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G1828
引用
收藏
页码：A417 / A417
页数：1
相关论文
共 50 条
  • [41] Gemcitabine, oxaliplatin and weekly high-dose 5-FU as a 24-hr-infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: Preliminary results of a multicenter phase II-study.
    Wagner, AD
    Buechner-Steudel, P
    Wein, A
    Masri-Zada, R
    Schmalenberg, H
    Kleber, G
    Kuss, O
    Moehler, M
    Behrens, R
    Fleig, WE
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 337S - 337S
  • [42] Phase II study of gemcitabine, UFT and leucovorin in patients with advanced pancreatic cancer
    Kim, TW
    Kang, HJ
    Ahn, JH
    Lee, K
    Chang, HM
    Kang, YK
    Lee, JS
    ACTA ONCOLOGICA, 2002, 41 (7-8) : 689 - 694
  • [43] A phase II study in patients with advanced biliary tract carcinoma (BTC) treated with hepatic arterial infusion chemotherapy (HAI) with oxaliplatin (O), 5-fluorouracil (5FU), and folinic acid (FA).
    Nicolaou, A.
    Sinn, M.
    Hildebrandt, B.
    Gebauer, B.
    Ricke, J.
    Doerken, B.
    Riess, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Oxaliplatin with weekly bolus 5-fluorouracil and leucovorin in pretreated advanced colorectal cancer patients: A phase II study
    Yang, TS
    Chen, JS
    Tang, RP
    Chiang, JM
    Hsieh, PS
    Yeh, CY
    Changchien, CR
    CHEMOTHERAPY, 2003, 49 (04) : 194 - 199
  • [45] Docetaxel and 5-FU in patients with advanced and recurrent gastric cancer: A multicenter phase II study
    Jung, Sang Seol
    Song, Byung-Joo
    Oh, Seong Taek
    Kim, Jeong Su
    Park, Cho Hyun
    Chun, Hae Myung
    Kim, Wook
    Chin, Hyung Min
    Park, Seung Man
    Kim, Seung Nam
    ANNALS OF ONCOLOGY, 2004, 15 : 237 - 237
  • [46] Multicenter phase II study of irinotecan plus weekly bolus 5-FU and high dose l-leucovorin for patients with metastatic colorectal cancer (OGSG 0201).
    Ishida, H
    Mishima, H
    Iwamoto, S
    Morimoto, T
    Kato, T
    Tsujinaka, T
    Furukawa, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 298S - 298S
  • [47] A phase I pharmacokinetic (PK) study of vorinostat (V) in combination with irinotecan (I), 5-fluorouracil (5FU), and leucovorin (FOLFIRI) in advanced upper gastrointestinal cancers (AGC)
    Fetterly, G. J.
    Brady, W. E.
    LeVea, C. M.
    Litwin, A. M.
    Zagst, P. D.
    Prey, J. D.
    Tarquini, M.
    Giardina, M. K.
    Iyer, R. V.
    Khushalani, N. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] 5-FU/leucovorin (5FU/LV) combined with irinotecan (CPT-11) and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma.
    Assaf, E.
    Verlinde-Carvalho, M.
    Delbaldo, C.
    Grenier, J.
    Sellam, Z.
    Pouessel, D.
    Sobhani, I.
    Tayar, C.
    Piedbois, P.
    Culine, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Taxotere-5FU Leucovorin (TFL) in advanced gastric carcinoma: A HeCOG phase II study
    Papakostas, P
    Kalofonos, HP
    Samelis, GF
    Konstantaras, C
    Bamias, A
    Skarlos, DV
    Kosmidis, P
    Fountzilas, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S154 - S154
  • [50] Combination of folinic acid, 5-fluorouracil bolus and infusion, and cisplatin (LV5FU2-P regimen) in patients with advanced gastric or gastroesophageal junction carcinoma
    Mitry, E
    Taïeb, J
    Artru, P
    Boige, V
    Vaillant, JN
    Clavero-Fabri, MC
    Ducreux, M
    Rougier, P
    ANNALS OF ONCOLOGY, 2004, 15 (05) : 765 - 769
12345